These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6193890)

  • 1. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.
    Prywes R; Foulkes JG; Rosenberg N; Baltimore D
    Cell; 1983 Sep; 34(2):569-79. PubMed ID: 6193890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus.
    Prywes R; Hoag J; Rosenberg N; Baltimore D
    J Virol; 1985 Apr; 54(1):123-32. PubMed ID: 2983109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome structure of Abelson murine leukemia virus variants: proviruses in fibroblasts and lymphoid cells.
    Goff SP; Witte ON; Gilboa E; Rosenberg N; Baltimore D
    J Virol; 1981 May; 38(2):460-8. PubMed ID: 6264122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule.
    Rosenberg N; Witte ON
    J Virol; 1980 Jan; 33(1):340-8. PubMed ID: 6245237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-directed deletions of Abelson murine leukemia virus define 3' sequences essential for transformation and lethality.
    Watanabe SM; Witte ON
    J Virol; 1983 Mar; 45(3):1028-36. PubMed ID: 6300444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity.
    Witte ON; Goff S; Rosenberg N; Baltimore D
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4993-7. PubMed ID: 6254050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphorylation at tyrosine residues in v-abl transformed mouse lymphocytes and fibroblasts.
    Saggioro D; Ferracini R; Di Renzo MF; Naldini L; Chieco-Bianchi L; Comoglio PM
    Int J Cancer; 1986 Apr; 37(4):623-8. PubMed ID: 2420727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus.
    Goff SP; Tabin CJ; Wang JY; Weinberg R; Baltimore D
    J Virol; 1982 Jan; 41(1):271-85. PubMed ID: 6283119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gag-derived but not abl-derived determinants are exposed on the surface of Abelson virus-transformed cells.
    Schiff-Maker L; Rosenberg N
    Virology; 1986 Oct; 154(2):286-301. PubMed ID: 3020782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.
    Watanabe SM; Rosenberg NE; Witte ON
    J Virol; 1984 Sep; 51(3):620-7. PubMed ID: 6088787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abelson murine leukemia virus: structural requirements for transforming gene function.
    Srinivasan A; Dunn CY; Yuasa Y; Devare SG; Reddy EP; Aaronson SA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5508-12. PubMed ID: 6291048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
    Engelman A; Rosenberg N
    J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular requirements for rapid plasmacytoma and pre-B lymphoma induction by Abelson murine leukemia virus in myc-transgenic mice.
    Sugiyama H; Wang Y; Jackson P; Sawyers CL; Klein G
    Int J Cancer; 1994 Jul; 58(1):135-41. PubMed ID: 8014009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of Abelson murine leukemia virus.
    Witte ON; Rosenberg N; Baltimore D
    Prog Clin Biol Res; 1980; 41():757-64. PubMed ID: 6256775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo tyrosine phosphorylations of the Abelson virus transforming protein are absent in its normal cellular homolog.
    Ponticelli AS; Whitlock CA; Rosenberg N; Witte ON
    Cell; 1982 Jul; 29(3):953-60. PubMed ID: 6185233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abelson murine leukemia virus induces platelet-derived growth factor-independent fibroblast growth: correlation with kinase activity and dissociation from full morphologic transformation.
    Rees-Jones RW; Goldfarb M; Goff SP
    Mol Cell Biol; 1989 Jan; 9(1):278-87. PubMed ID: 2538721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation.
    Rosenberg NE; Clark DR; Witte ON
    J Virol; 1980 Dec; 36(3):766-74. PubMed ID: 6257926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.